Jpmorgan Chase & Co »

Structure Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $320k 7.8k 40.76
2023-09-30 $2.0M 40k 50.42